Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007005
Filing Date
2025-05-08
Accepted
2025-05-08 17:04:27
Documents
75
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mxct-20250331x10q.htm   iXBRL 10-Q 1296879
2 EX-10.1 mxct-20250331xex10d1.htm EX-10.1 98347
3 EX-10.2 mxct-20250331xex10d2.htm EX-10.2 107002
4 EX-31.1 mxct-20250331xex31d1.htm EX-31.1 15553
5 EX-31.2 mxct-20250331xex31d2.htm EX-31.2 14801
6 EX-32.1 mxct-20250331xex32d1.htm EX-32.1 7614
7 EX-32.2 mxct-20250331xex32d2.htm EX-32.2 7007
  Complete submission text file 0001558370-25-007005.txt   6712185

Data Files

Seq Description Document Type Size
8 EX-101.SCH mxct-20250331.xsd EX-101.SCH 42212
9 EX-101.CAL mxct-20250331_cal.xml EX-101.CAL 61091
10 EX-101.DEF mxct-20250331_def.xml EX-101.DEF 180168
11 EX-101.LAB mxct-20250331_lab.xml EX-101.LAB 410192
12 EX-101.PRE mxct-20250331_pre.xml EX-101.PRE 310420
78 EXTRACTED XBRL INSTANCE DOCUMENT mxct-20250331x10q_htm.xml XML 1061324
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40674 | Film No.: 25927250
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)